NM-301

N/A

Report date: 2024/02/06 15:03:31

Base Information

Drug NameNM-301
Drug Alias NameGene therapy drug based on AAV vector expressing HGF（Helixmith）NM-301NM301
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionNADPH oxidase modulators
TargetsNADPH oxidase
Therapy Area/IndicationsMotor Neuron DiseaseAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHelixmith Co LtdNeuromyon
China Registration ClassN/A

Develop Information

Active CompaniesNeuromyonHelixmith Co Ltd
Inactive CompaniesN/A
Active IndicationsMotor Neuron DiseaseAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A